510(k) Report

PMA · Approved

Approved

Viratype Human Papillomavirus Dna Typing Kit

P890064PMAApproved Mar 11, 1991479-day reviewClass III

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Qiagen Gaithersburg, Inc. · MAQ Kit, Dna Detection, Human Papillomavirus

Approved on Mar 11, 1991 through premarket approval, which rests on the device’s own clinical evidence after a 479-day review.

Decided
Mar 11, 1991
Review
479 days
Class
Class III
Product code
MAQ
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P890064 has 37 supplements since 1993: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

1993: 11994: 11995: 11996: 11997: 11999: 12000: 22003: 32004: 32006: 12009: 12010: 42011: 22012: 12014: 32015: 12016: 12017: 22018: 52020: 12023: 1
1993high 5 (2018) · low 0 (1998)2023
View FIG. 1 as a table
YearSupplements approved
19931
19941
19951
19961
19971
19991
20002
20033
20043
20061
20091
20104
20112
20121
20143
20151
20161
20172
20185
20201
20231
FIG. 1 — Supplements to P890064, 1993–2023Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MAQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All MAQ devices

MAQ Kit, Dna Detection, Human Papillomavirus: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MAQ

14in 2025

2009: 42010: 82011: 132012: 122013: 122014: 82015: 52016: 62017: 82018: 282019: 112020: 142021: 22022: 42023: 182024: 172025: 142026 (partial year): 19
2007high 28 (2018) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MAQ

Too few MAQ 510(k)s in any year since 2007 to give a median.

Recalls per year · MAQ

1in 2025

2020: 12024: 22025: 1
2007high 2 (2024) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MAQ

95in 2025

2011: 32012: 42013: 72016: 22017: 32018: 22020: 12021: 92022: 42023: 342024: 682025: 95
2007high 95 (2025) · low 0 (2007)2025

MAUDE reports naming product code MAQ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20094—00
20108—00
201113—03
201212—04
201312—07
20148—00
20155—00
20166—02
20178—03
201828—02
201911—00
202014—11
20212—09
20224—04
202318—034
202417—268
202514—195
202619—0—
Cite this page

510(k) Report. “P890064: Viratype Human Papillomavirus Dna Typing Kit.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P890064

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026